-+ 0.00%
-+ 0.00%
-+ 0.00%

Stephens & Co. Maintains Equal-Weight on Medifast, Lowers Price Target to $12

Benzinga·02/19/2026 13:34:32
Listen to the news
Stephens & Co. analyst Jim Salera maintains Medifast (NYSE:MED) with a Equal-Weight and lowers the price target from $15 to $12.